Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China

Table 2 The incidence of symptoms in patients with coronavirus disease 2019 at the time of admission (%)

Symptom (%)	T (n = 48)	A (n = 31)	B (n = 17)	χ2 (P value1)	C (n = 14)	D (n = 34)	χ2 (P value2)	E (n = 38)	F (n = 9)	χ2 (P value3)
Fever	89.6 (43)	93.5 (29)	82.4 (14)	0.5189 (> 0.25)	71.4 (10)	67.6 (23)	0.0073 (> 0.9)	92.1 (35)	88.9 (8)	0.1238 (> 0.5)
Cough and expectoration	85.4 (41)	87.1 (27)	82.4 (14)	0.0013 (> 0.9)	71.4 (10)	91.2 (31)	1.722 (> 0.1)	86.8 (33)	88.9 (8)	0.0276 (> 0.5)
Chill	45.8 (22)	51.6 (16)	35.3 (6)	1.1777 (> 0.25)	42.9 (6)	47.1 (16)	0.0705 (> 0.75)	47.4 (18)	44.4 (4)	0.0455 (> 0.5)
Fatigue	45.8 (22)	45.2 (14)	47.1 (8)	0.7802 (> 0.25)	50 (7)	44.1 (15)	0.1382 (> 0.75)	44.7 (17)	55.6 (5)	0.0455 (> 0.5)
Poor appetite	27.1 (13)	25.8 (8)	29.4 (5)	1.1868 (> 0.25)	35.7 (5)	23.5 (8)	0.2562 (> 0.5)	23.7 (9)	44.4 (4)	0.9938 (> 0.25)
Sore throat	18.8 (9)	16.1 (5)	23.5 (4)	0.0584 (> 0.25)	21.4 (3)	17.6 (6)	0.0103 (> 0.9)	18.4 (7)	11.1 (1)	0.00099 (> 0.9)
Dyspnea	18.8 (9)	16.1 (5)	23.5 (4)	0.0584 (> 0.25)	14.3 (2)	20.6 (7)	0.0103 (> 0.9)	13.2 (5)	44.4 (4)	2.8017 (> 0.05)
Diarrhea	14.6 (7)	6.5 (2)	29.4 (5)	4.494 (> 0.25)	14.3 (2)	14.7 (5)	0.1701 (> 0.5)	7.9 (3)	33.3 (3)	2.2526 (> 0.1)
Dizziness	10.4 (5)	6.5 (2)	17.6 (3)	0.5189 (> 0.25)	21.4 (3)	5.9 (2)	1.1726 (> 0.25)	10.5 (4)	11.1 (1)	0.3025 (> 0.5)
Headache	10.4 (5)	12.9 (4)	5.9 (1)	0.1413 (> 0.25)	0 (0)	14.7 (5)	0.9925 (> 0.25)	7.9 (3)	22.2 (2)	0.4255 (> 0.1)
Muscle ache	10.4 (5)	3.2 (1)	23.5 (4)	2.9184 (> 0.05)	14.3 (2)	8.8 (3)	0.0019 (> 0.9)	10.5 (4)	11.1 (1)	0.3025 (> 0.9)
Nausea and vomiting	8.3 (4)	6.5 (2)	11.8 (2)	0.0083 (> 0.5)	7.1 (1)	8.8 (3)	0.1467 (> 0.9)	10.5 (4)	0 (0)	0.1248 (> 0.5)
Hemoptysis	8.3 (4)	6.5 (2)	11.8 (2)	0.0083 (> 0.05)	7.1 (1)	8.8 (3)	0.1467 (> 0.9)	7.9 (3)	11.1 (1)	0.1248 (> 0.5)
Runny nose	2.1 (1)	3.2 (1)	0 (0)	0.0949 (> 0.5)	0 (0)	2.9 (1)	0.2146 (> 0.5)	2.6 (1)	0 (0)	0.6281 (> 0.25)

¹Indicates differences between male and female patients.

²Denotes differences between patients with and without basic diseases.

³Represents differences between moderate and severe patients. P < 0.05 was considered statistically significant. T: All patients; A: Male; B: Female; C: With basic diseases; D: Without basic diseases; E: Moderate; F: Severe.